HIIFS
CBPO

Harel Insurance Investments & Financial Services’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-284
Closed -$31K – 613
2020
Q1 		$31K Sell
284
-333
-54% -$38.3K ﹤0.01% 305
2019
Q4 		$72K Buy
617
+510
+477% +$59.1K ﹤0.01% 324
2019
Q3 		$12K Buy
+107
New +$10.6K ﹤0.01% 432

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Harel Insurance Investments & Financial Services's CBPO Position: Q2 2020 in Review

Harel Insurance Investments & Financial Services sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 284 shares — an estimated $31K sold.

Harel Insurance Investments & Financial Services first reported a position in CBPO in Q3 2019 and held it in 3 quarters. The position peaked at $72K in Q4 2019. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

  • Harel Insurance Investments & Financial Services reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 284 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $31K.
  • Harel Insurance Investments & Financial Services first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 3 quarters.
  • Harel Insurance Investments & Financial Services's China Biologic Products Holdings, Inc. position peaked at $72K in Q4 2019.
  • 91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2020, filed 14 Jul 2020.